img

Global Ivermectin for Human Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Ivermectin for Human Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Ivermectin for Human report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Ivermectin for Human market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from For Onchocerciasis Treatment and For Headlice Treatment are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Ivermectin for Human industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Ivermectin for Human key manufacturers include Merck, Perrigo Company plc, Arbor Pharms LLC, TARO, Edenbridge Pharms, TEVA Pharms USA, Wellona Pharma and Galderma Laboratories LP, etc. Merck, Perrigo Company plc, Arbor Pharms LLC are top 3 players and held % sales share in total in 2022.
Ivermectin for Human can be divided into Topical (Cream and Lotion), Oral and Injection,, etc. Topical (Cream and Lotion) is the mainstream product in the market, accounting for % sales share globally in 2022.
Ivermectin for Human is widely used in various fields, such as For Onchocerciasis Treatment, For Headlice Treatment and Others,, etc. For Onchocerciasis Treatment provides greatest supports to the Ivermectin for Human industry development. In 2022, global % sales of Ivermectin for Human went into For Onchocerciasis Treatment filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Ivermectin for Human market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Merck
Perrigo Company plc
Arbor Pharms LLC
TARO
Edenbridge Pharms
TEVA Pharms USA
Wellona Pharma
Galderma Laboratories LP
Segment by Type
Topical (Cream and Lotion)
Oral
Injection

Segment by Application


For Onchocerciasis Treatment
For Headlice Treatment
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Ivermectin for Human market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Ivermectin for Human, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Ivermectin for Human industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Ivermectin for Human in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Ivermectin for Human introduction, etc. Ivermectin for Human Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Ivermectin for Human market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Ivermectin for Human Market Overview
1.1 Ivermectin for Human Product Overview
1.2 Ivermectin for Human Market Segment by Type
1.2.1 Topical (Cream and Lotion)
1.2.2 Oral
1.2.3 Injection
1.3 Global Ivermectin for Human Market Size by Type
1.3.1 Global Ivermectin for Human Market Size Overview by Type (2024-2034)
1.3.2 Global Ivermectin for Human Historic Market Size Review by Type (2024-2024)
1.3.3 Global Ivermectin for Human Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Ivermectin for Human Sales Breakdown by Type (2024-2024)
1.4.2 Europe Ivermectin for Human Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Ivermectin for Human Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Ivermectin for Human Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Ivermectin for Human Sales Breakdown by Type (2024-2024)
2 Global Ivermectin for Human Market Competition by Company
2.1 Global Top Players by Ivermectin for Human Sales (2024-2024)
2.2 Global Top Players by Ivermectin for Human Revenue (2024-2024)
2.3 Global Top Players by Ivermectin for Human Price (2024-2024)
2.4 Global Top Manufacturers Ivermectin for Human Manufacturing Base Distribution, Sales Area, Product Type
2.5 Ivermectin for Human Market Competitive Situation and Trends
2.5.1 Ivermectin for Human Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Ivermectin for Human Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Ivermectin for Human as of 2022)
2.7 Date of Key Manufacturers Enter into Ivermectin for Human Market
2.8 Key Manufacturers Ivermectin for Human Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Ivermectin for Human Status and Outlook by Region
3.1 Global Ivermectin for Human Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Ivermectin for Human Historic Market Size by Region
3.2.1 Global Ivermectin for Human Sales in Volume by Region (2024-2024)
3.2.2 Global Ivermectin for Human Sales in Value by Region (2024-2024)
3.2.3 Global Ivermectin for Human Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Ivermectin for Human Forecasted Market Size by Region
3.3.1 Global Ivermectin for Human Sales in Volume by Region (2024-2034)
3.3.2 Global Ivermectin for Human Sales in Value by Region (2024-2034)
3.3.3 Global Ivermectin for Human Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Ivermectin for Human by Application
4.1 Ivermectin for Human Market Segment by Application
4.1.1 For Onchocerciasis Treatment
4.1.2 For Headlice Treatment
4.1.3 Others
4.2 Global Ivermectin for Human Market Size by Application
4.2.1 Global Ivermectin for Human Market Size Overview by Application (2024-2034)
4.2.2 Global Ivermectin for Human Historic Market Size Review by Application (2024-2024)
4.2.3 Global Ivermectin for Human Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Ivermectin for Human Sales Breakdown by Application (2024-2024)
4.3.2 Europe Ivermectin for Human Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Ivermectin for Human Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Ivermectin for Human Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Ivermectin for Human Sales Breakdown by Application (2024-2024)
5 North America Ivermectin for Human by Country
5.1 North America Ivermectin for Human Historic Market Size by Country
5.1.1 North America Ivermectin for Human Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Ivermectin for Human Sales in Volume by Country (2024-2024)
5.1.3 North America Ivermectin for Human Sales in Value by Country (2024-2024)
5.2 North America Ivermectin for Human Forecasted Market Size by Country
5.2.1 North America Ivermectin for Human Sales in Volume by Country (2024-2034)
5.2.2 North America Ivermectin for Human Sales in Value by Country (2024-2034)
6 Europe Ivermectin for Human by Country
6.1 Europe Ivermectin for Human Historic Market Size by Country
6.1.1 Europe Ivermectin for Human Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Ivermectin for Human Sales in Volume by Country (2024-2024)
6.1.3 Europe Ivermectin for Human Sales in Value by Country (2024-2024)
6.2 Europe Ivermectin for Human Forecasted Market Size by Country
6.2.1 Europe Ivermectin for Human Sales in Volume by Country (2024-2034)
6.2.2 Europe Ivermectin for Human Sales in Value by Country (2024-2034)
7 Asia-Pacific Ivermectin for Human by Region
7.1 Asia-Pacific Ivermectin for Human Historic Market Size by Region
7.1.1 Asia-Pacific Ivermectin for Human Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Ivermectin for Human Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Ivermectin for Human Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Ivermectin for Human Forecasted Market Size by Region
7.2.1 Asia-Pacific Ivermectin for Human Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Ivermectin for Human Sales in Value by Region (2024-2034)
8 Latin America Ivermectin for Human by Country
8.1 Latin America Ivermectin for Human Historic Market Size by Country
8.1.1 Latin America Ivermectin for Human Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Ivermectin for Human Sales in Volume by Country (2024-2024)
8.1.3 Latin America Ivermectin for Human Sales in Value by Country (2024-2024)
8.2 Latin America Ivermectin for Human Forecasted Market Size by Country
8.2.1 Latin America Ivermectin for Human Sales in Volume by Country (2024-2034)
8.2.2 Latin America Ivermectin for Human Sales in Value by Country (2024-2034)
9 Middle East and Africa Ivermectin for Human by Country
9.1 Middle East and Africa Ivermectin for Human Historic Market Size by Country
9.1.1 Middle East and Africa Ivermectin for Human Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Ivermectin for Human Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Ivermectin for Human Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Ivermectin for Human Forecasted Market Size by Country
9.2.1 Middle East and Africa Ivermectin for Human Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Ivermectin for Human Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Merck
10.1.1 Merck Company Information
10.1.2 Merck Introduction and Business Overview
10.1.3 Merck Ivermectin for Human Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Merck Ivermectin for Human Products Offered
10.1.5 Merck Recent Development
10.2 Perrigo Company plc
10.2.1 Perrigo Company plc Company Information
10.2.2 Perrigo Company plc Introduction and Business Overview
10.2.3 Perrigo Company plc Ivermectin for Human Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Perrigo Company plc Ivermectin for Human Products Offered
10.2.5 Perrigo Company plc Recent Development
10.3 Arbor Pharms LLC
10.3.1 Arbor Pharms LLC Company Information
10.3.2 Arbor Pharms LLC Introduction and Business Overview
10.3.3 Arbor Pharms LLC Ivermectin for Human Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Arbor Pharms LLC Ivermectin for Human Products Offered
10.3.5 Arbor Pharms LLC Recent Development
10.4 TARO
10.4.1 TARO Company Information
10.4.2 TARO Introduction and Business Overview
10.4.3 TARO Ivermectin for Human Sales, Revenue and Gross Margin (2024-2024)
10.4.4 TARO Ivermectin for Human Products Offered
10.4.5 TARO Recent Development
10.5 Edenbridge Pharms
10.5.1 Edenbridge Pharms Company Information
10.5.2 Edenbridge Pharms Introduction and Business Overview
10.5.3 Edenbridge Pharms Ivermectin for Human Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Edenbridge Pharms Ivermectin for Human Products Offered
10.5.5 Edenbridge Pharms Recent Development
10.6 TEVA Pharms USA
10.6.1 TEVA Pharms USA Company Information
10.6.2 TEVA Pharms USA Introduction and Business Overview
10.6.3 TEVA Pharms USA Ivermectin for Human Sales, Revenue and Gross Margin (2024-2024)
10.6.4 TEVA Pharms USA Ivermectin for Human Products Offered
10.6.5 TEVA Pharms USA Recent Development
10.7 Wellona Pharma
10.7.1 Wellona Pharma Company Information
10.7.2 Wellona Pharma Introduction and Business Overview
10.7.3 Wellona Pharma Ivermectin for Human Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Wellona Pharma Ivermectin for Human Products Offered
10.7.5 Wellona Pharma Recent Development
10.8 Galderma Laboratories LP
10.8.1 Galderma Laboratories LP Company Information
10.8.2 Galderma Laboratories LP Introduction and Business Overview
10.8.3 Galderma Laboratories LP Ivermectin for Human Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Galderma Laboratories LP Ivermectin for Human Products Offered
10.8.5 Galderma Laboratories LP Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Ivermectin for Human Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Ivermectin for Human Industrial Chain Analysis
11.4 Ivermectin for Human Market Dynamics
11.4.1 Ivermectin for Human Industry Trends
11.4.2 Ivermectin for Human Market Drivers
11.4.3 Ivermectin for Human Market Challenges
11.4.4 Ivermectin for Human Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Ivermectin for Human Distributors
12.3 Ivermectin for Human Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Topical (Cream and Lotion)
Table 2. Major Company of Oral
Table 3. Major Company of Injection
Table 4. Global Ivermectin for Human Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 5. Global Ivermectin for Human Sales by Type (2024-2024) & (KG)
Table 6. Global Ivermectin for Human Sales Market Share in Volume by Type (2024-2024)
Table 7. Global Ivermectin for Human Sales by Type (2024-2024) & (US& Million)
Table 8. Global Ivermectin for Human Market Share in Value by Type (2024-2024)
Table 9. Global Ivermectin for Human Price by Type (2024-2024) & (USD/g)
Table 10. Global Ivermectin for Human Sales by Type (2024-2034) & (KG)
Table 11. Global Ivermectin for Human Sales Market Share in Volume by Type (2024-2034)
Table 12. Global Ivermectin for Human Sales by Type (2024-2034) & (US$ Million)
Table 13. Global Ivermectin for Human Sales Market Share in Value by Type (2024-2034)
Table 14. Global Ivermectin for Human Price by Type (2024-2034) & (USD/g)
Table 15. North America Ivermectin for Human Sales by Type (2024-2024) & (KG)
Table 16. North America Ivermectin for Human Sales by Type (2024-2024) & (US$ Million)
Table 17. Europe Ivermectin for Human Sales (KG) by Type (2024-2024)
Table 18. Europe Ivermectin for Human Sales by Type (2024-2024) & (US$ Million)
Table 19. Asia-Pacific Ivermectin for Human Sales (KG) by Type (2024-2024)
Table 20. Asia-Pacific Ivermectin for Human Sales by Type (2024-2024) & (US$ Million)
Table 21. Latin America Ivermectin for Human Sales (KG) by Type (2024-2024)
Table 22. Latin America Ivermectin for Human Sales by Type (2024-2024) & (US$ Million)
Table 23. Middle East and Africa Ivermectin for Human Sales (KG) by Type (2024-2024)
Table 24. Middle East and Africa Ivermectin for Human Sales by Type (2024-2024) & (US$ Million)
Table 25. Global Ivermectin for Human Sales by Company (2024-2024) & (KG)
Table 26. Global Ivermectin for Human Sales Share by Company (2024-2024)
Table 27. Global Ivermectin for Human Revenue by Company (2024-2024) & (US$ Million)
Table 28. Global Ivermectin for Human Revenue Share by Company (2024-2024)
Table 29. Global Market Ivermectin for Human Price by Company (2024-2024) & (USD/g)
Table 30. Global Ivermectin for Human Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Ivermectin for Human Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Ivermectin for Human as of 2022)
Table 33. Date of Key Manufacturers Enter into Ivermectin for Human Market
Table 34. Key Manufacturers Ivermectin for Human Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Ivermectin for Human Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 37. Global Ivermectin for Human Sales by Region (2024-2024) & (KG)
Table 38. Global Ivermectin for Human Sales Market Share in Volume by Region (2024-2024)
Table 39. Global Ivermectin for Human Sales by Region (2024-2024) & (US$ Million)
Table 40. Global Ivermectin for Human Sales Market Share in Value by Region (2024-2024)
Table 41. Global Ivermectin for Human Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2024-2024)
Table 42. Global Ivermectin for Human Sales by Region (2024-2034) & (KG)
Table 43. Global Ivermectin for Human Sales Market Share in Volume by Region (2024-2034)
Table 44. Global Ivermectin for Human Sales by Region (2024-2034) & (US$ Million)
Table 45. Global Ivermectin for Human Sales Market Share in Value by Region (2024-2034)
Table 46. Global Ivermectin for Human Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2024-2034)
Table 47. Global Ivermectin for Human Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 48. Global Ivermectin for Human Sales by Application (2024-2024) & (KG)
Table 49. Global Ivermectin for Human Sales Market Share in Volume by Application (2024-2024)
Table 50. Global Ivermectin for Human Sales by Application (2024-2024) & (US$ Million)
Table 51. Global Ivermectin for Human Sales Market Share in Value by Application (2024-2024)
Table 52. Global Ivermectin for Human Price by Application (2024-2024) & (USD/g)
Table 53. Global Ivermectin for Human Sales by Application (2024-2034) & (KG)
Table 54. Global Ivermectin for Human Sales Market Share in Volume by Application (2024-2034)
Table 55. Global Ivermectin for Human Sales by Application (2024-2034) & (US$ Million)
Table 56. Global Ivermectin for Human Sales Market Share in Value by Application (2024-2034)
Table 57. Global Ivermectin for Human Price by Application (2024-2034) & (USD/g)
Table 58. North America Ivermectin for Human Sales by Application (2024-2024) (KG)
Table 59. North America Ivermectin for Human Sales by Application (2024-2024) & (US$ Million)
Table 60. Europe Ivermectin for Human Sales by Application (2024-2024) (KG)
Table 61. Europe Ivermectin for Human Sales by Application (2024-2024) & (US$ Million)
Table 62. Asia-Pacific Ivermectin for Human Sales by Application (2024-2024) (KG)
Table 63. Asia-Pacific Ivermectin for Human Sales by Application (2024-2024) & (US$ Million)
Table 64. Latin America Ivermectin for Human Sales by Application (2024-2024) (KG)
Table 65. Latin America Ivermectin for Human Sales by Application (2024-2024) & (US$ Million)
Table 66. Middle East and Africa Ivermectin for Human Sales by Application (2024-2024) (KG)
Table 67. Middle East and Africa Ivermectin for Human Sales by Application (2024-2024) & (US$ Million)
Table 68. North America Ivermectin for Human Sales by Country (2024-2024) & (KG)
Table 69. North America Ivermectin for Human Sales Market Share in Volume by Country (2024-2024)
Table 70. North America Ivermectin for Human Sales by Country (2024-2024) & (US$ Million)
Table 71. North America Ivermectin for Human Sales Market Share in Value by Country (2024-2024)
Table 72. North America Ivermectin for Human Sales by Country (2024-2034) & (KG)
Table 73. North America Ivermectin for Human Sales Market Share in Volume by Country (2024-2034)
Table 74. North America Ivermectin for Human Sales by Country (2024-2034) & (US$ Million)
Table 75. North America Ivermectin for Human Sales Market Share in Value by Country (2024-2034)
Table 76. Europe Ivermectin for Human Sales by Country (2024-2024) & (KG)
Table 77. Europe Ivermectin for Human Sales Market Share in Volume by Country (2024-2024)
Table 78. Europe Ivermectin for Human Sales by Country (2024-2024) & (US$ Million)
Table 79. Europe Ivermectin for Human Sales Market Share in Value by Country (2024-2024)
Table 80. Europe Ivermectin for Human Sales by Country (2024-2034) & (KG)
Table 81. Europe Ivermectin for Human Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe Ivermectin for Human Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe Ivermectin for Human Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific Ivermectin for Human Sales by Region (2024-2024) & (KG)
Table 85. Asia-Pacific Ivermectin for Human Sales Market Share in Volume by Region (2024-2024)
Table 86. Asia-Pacific Ivermectin for Human Sales by Region (2024-2024) & (US$ Million)
Table 87. Asia-Pacific Ivermectin for Human Sales Market Share in Value by Region (2024-2024)
Table 88. Asia-Pacific Ivermectin for Human Sales by Region (2024-2034) & (KG)
Table 89. Asia-Pacific Ivermectin for Human Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific Ivermectin for Human Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Ivermectin for Human Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America Ivermectin for Human Sales by Country (2024-2024) & (KG)
Table 93. Latin America Ivermectin for Human Sales Market Share in Volume by Country (2024-2024)
Table 94. Latin America Ivermectin for Human Sales by Country (2024-2024) & (US$ Million)
Table 95. Latin America Ivermectin for Human Sales Market Share in Value by Country (2024-2024)
Table 96. Latin America Ivermectin for Human Sales by Country (2024-2034) & (KG)
Table 97. Latin America Ivermectin for Human Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America Ivermectin for Human Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America Ivermectin for Human Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa Ivermectin for Human Sales by Country (2024-2024) & (KG)
Table 101. Middle East and Africa Ivermectin for Human Sales Market Share in Volume by Country (2024-2024)
Table 102. Middle East and Africa Ivermectin for Human Sales by Country (2024-2024) & (US$ Million)
Table 103. Middle East and Africa Ivermectin for Human Sales Market Share in Value by Country (2024-2024)
Table 104. Middle East and Africa Ivermectin for Human Sales by Country (2024-2034) & (KG)
Table 105. Middle East and Africa Ivermectin for Human Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa Ivermectin for Human Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa Ivermectin for Human Sales Market Share in Value by Country (2024-2034)
Table 108. Merck Company Information
Table 109. Merck Introduction and Business Overview
Table 110. Merck Ivermectin for Human Sales (KG), Revenue (Million USD), Price (USD/g) and Gross Margin (2024-2024)
Table 111. Merck Ivermectin for Human Product
Table 112. Merck Recent Development
Table 113. Perrigo Company plc Company Information
Table 114. Perrigo Company plc Introduction and Business Overview
Table 115. Perrigo Company plc Ivermectin for Human Sales (KG), Revenue (Million USD), Price (USD/g) and Gross Margin (2024-2024)
Table 116. Perrigo Company plc Ivermectin for Human Product
Table 117. Perrigo Company plc Recent Development
Table 118. Arbor Pharms LLC Company Information
Table 119. Arbor Pharms LLC Introduction and Business Overview
Table 120. Arbor Pharms LLC Ivermectin for Human Sales (KG), Revenue (Million USD), Price (USD/g) and Gross Margin (2024-2024)
Table 121. Arbor Pharms LLC Ivermectin for Human Product
Table 122. Arbor Pharms LLC Recent Development
Table 123. TARO Company Information
Table 124. TARO Introduction and Business Overview
Table 125. TARO Ivermectin for Human Sales (KG), Revenue (Million USD), Price (USD/g) and Gross Margin (2024-2024)
Table 126. TARO Ivermectin for Human Product
Table 127. TARO Recent Development
Table 128. Edenbridge Pharms Company Information
Table 129. Edenbridge Pharms Introduction and Business Overview
Table 130. Edenbridge Pharms Ivermectin for Human Sales (KG), Revenue (Million USD), Price (USD/g) and Gross Margin (2024-2024)
Table 131. Edenbridge Pharms Ivermectin for Human Product
Table 132. Edenbridge Pharms Recent Development
Table 133. TEVA Pharms USA Company Information
Table 134. TEVA Pharms USA Introduction and Business Overview
Table 135. TEVA Pharms USA Ivermectin for Human Sales (KG), Revenue (Million USD), Price (USD/g) and Gross Margin (2024-2024)
Table 136. TEVA Pharms USA Ivermectin for Human Product
Table 137. TEVA Pharms USA Recent Development
Table 138. Wellona Pharma Company Information
Table 139. Wellona Pharma Introduction and Business Overview
Table 140. Wellona Pharma Ivermectin for Human Sales (KG), Revenue (Million USD), Price (USD/g) and Gross Margin (2024-2024)
Table 141. Wellona Pharma Ivermectin for Human Product
Table 142. Wellona Pharma Recent Development
Table 143. Galderma Laboratories LP Company Information
Table 144. Galderma Laboratories LP Introduction and Business Overview
Table 145. Galderma Laboratories LP Ivermectin for Human Sales (KG), Revenue (Million USD), Price (USD/g) and Gross Margin (2024-2024)
Table 146. Galderma Laboratories LP Ivermectin for Human Product
Table 147. Galderma Laboratories LP Recent Development
Table 148. Key Raw Materials Lists
Table 149. Raw Materials Key Suppliers Lists
Table 150. Ivermectin for Human Market Trends
Table 151. Ivermectin for Human Market Drivers
Table 152. Ivermectin for Human Market Challenges
Table 153. Ivermectin for Human Market Restraints
Table 154. Ivermectin for Human Distributors List
Table 155. Ivermectin for Human Downstream Customers
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Ivermectin for Human Product Picture
Figure 2. Global Ivermectin for Human Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Ivermectin for Human Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Ivermectin for Human Sales Status and Outlook (2024-2034) & (KG)
Figure 5. Product Picture of Topical (Cream and Lotion)
Figure 6. Global Topical (Cream and Lotion) Sales YoY Growth (2024-2034) & (KG)
Figure 7. Product Picture of Oral
Figure 8. Global Oral Sales YoY Growth (2024-2034) & (KG)
Figure 9. Product Picture of Injection
Figure 10. Global Injection Sales YoY Growth (2024-2034) & (KG)
Figure 11. Global Ivermectin for Human Sales by Type (2024-2034) & (US$ Million)
Figure 12. Global Ivermectin for Human Sales Market Share by Type in 2022 & 2034
Figure 13. North America Ivermectin for Human Sales Market Share in Volume by Type in 2022
Figure 14. North America Ivermectin for Human Sales Market Share in Value by Type in 2022
Figure 15. Europe Ivermectin for Human Sales Market Share in Volume by Type in 2022
Figure 16. Europe Ivermectin for Human Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Ivermectin for Human Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Ivermectin for Human Sales Market Share in Value by Type in 2022
Figure 19. Latin America Ivermectin for Human Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Ivermectin for Human Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Ivermectin for Human Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Ivermectin for Human Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Ivermectin for Human Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Ivermectin for Human Revenue in 2022
Figure 25. Ivermectin for Human Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 26. Product Picture of For Onchocerciasis Treatment
Figure 27. Global For Onchocerciasis Treatment Sales YoY Growth (2024-2034) & (KG)
Figure 28. Product Picture of For Headlice Treatment
Figure 29. Global For Headlice Treatment Sales YoY Growth (2024-2034) & (KG)
Figure 30. Product Picture of Others
Figure 31. Global Others Sales YoY Growth (2024-2034) & (KG)
Figure 32. Global Ivermectin for Human Sales by Application (2024-2034) & (US$ Million)
Figure 33. Global Ivermectin for Human Sales Market Share by Application in 2022 & 2034
Figure 34. North America Ivermectin for Human Sales Market Share in Volume by Application in 2022
Figure 35. North America Ivermectin for Human Sales Market Share in Value by Application in 2022
Figure 36. Europe Ivermectin for Human Sales Market Share in Volume by Application in 2022
Figure 37. Europe Ivermectin for Human Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Ivermectin for Human Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Ivermectin for Human Sales Market Share in Value by Application in 2022
Figure 40. Latin America Ivermectin for Human Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Ivermectin for Human Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Ivermectin for Human Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Ivermectin for Human Manufacturing Cost Structure
Figure 45. Ivermectin for Human Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed